期刊文献+

巨噬细胞游走抑制因子与成人斯蒂尔病病情活动的相关性研究 被引量:4

The association of macrophage migration inhibitory factor with disease activity of adult-onset Stili's disease
原文传递
导出
摘要 目的研究成人斯蒂尔病(AOSD)患者血清及外周血细胞内巨噬细胞游走抑制因子(MIF).分析MIF与AOSD疾病病情活动的相关性,并初步探讨其在疾病中的发病机制。方法采用酶联免疫吸附法检测了20名健康对照、57例AOSD患者及其中13例随访患者血清中MIF水平,并采用三色法流式细胞术比较5例AOSD患者及6名健康对照外周血细胞内MIF含量。结果AOSD患者血清中MIF的水平为(204±228)ng/ml,较健康对照(27±19)ng/ml显著增高(P〈0.01)。血清MIF水平在具有咽痛、肌痛、脾大或浆膜炎表现的患者中显著增高(P〈0.05),并与病情严重程度(系统评分)显著相关(P〈0.01)。在对13例患者随访后发现血清中MIF水平与疾病活动性显著相关(P=0.003)。AOSD患者外周血单核细胞、T细胞中MIF水平显著高于健康对照(P〈0.05),而B细胞及粒细胞中MIF水平与健康对照差异无统计学意义(P〉0.05)。结论MIF为AOSD良好的疾病病情严重程度及活动性的监测指标,并可能在致病机制中发挥着重要作用。 Objective To test the macrophage migration inhibitory factor (MIF) levels in serum and peripheral blood cells of patients with adult-onset Still's disease (AOSD), and analyze its relationship with disease activity. In addition, the role of MIF in the pathogenesis of AOSD is explored. Methods Serum MIF concentrations were detected by enzyme-linked immunosorbent assay (ELISA), and intracellular MIF production by peripheral blood cells were detected by three-color permeabilization flow cytometry. Results Serum MIF levels were significantly higher in AOSD (204±228) ng/ml than those in healthy controls (27±19) ng/ml, P〈0.01. MIF levels in patients with sore throat, myalgia, splenomegaly or pleuritis were higher than those without (P〈0.05). Furthermore, serum MIF levels were correlated with disease severity (P〈O.O1) and activity (P=0.003). In addition, intracellular MIF production in monocytes, T cells were significantly increased in patients with AOSD than in healthy controls, but no significant difference was observed in B cells and granulocytes. Conclusion MIF levels may be used as a favorable marker for disease severity evaluation and monitoring, and possibly play an important role in the pathogenesis of AOSD.
出处 《中华风湿病学杂志》 CAS CSCD 2007年第12期705-708,共4页 Chinese Journal of Rheumatology
基金 国家自然科学基金资助项目(30671946) 上海市重点学科建设资助项目(T0203)
关键词 STILL病 成年型 巨噬细胞游走抑制因子 Still's disease, adult-onset Macrophage migration inhibitory factor
  • 相关文献

参考文献13

  • 1Efthimiou P, Georgy S. Pathogenesis and management of adultonset Still's disease. Semin Arthritis Rheum, 2006, 36: 144-152.
  • 2Calandra T, Roger T. Macrophage migration inhibitory factor, a regulator of innate immunity. Nat Rev Immunol, 2003, 3: 791- 800.
  • 3Pouchot J, Sampalis JS, Beaudet F, et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine (Baltimore), 1991, 70:118-136.
  • 4Tabak F, Mert A, Celik AD, et al. Fever of unknown origin in Turkey. Infection, 2003, 31: 417-420.
  • 5Calandra T, Echtenacher B, Le Roy D, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor (MIF). Nat Med, 2000, 6: 164-169.
  • 6Morand EF, Leech M, Weedon H, et al. Macrophage migration inhibitory factor in rheumatoid arthritis:clinical correlations. Rheumatology, 2002, 41: 558-562.
  • 7陈伟英,李广然,方芳,阳晓,何新生,周飞宇,余学清.外周血单个核细胞巨噬细胞移动抑制因子表达及其与狼疮活动[J].中华内科杂志,2004,43(8):572-575. 被引量:10
  • 8Leech M, Metz C, Santos L, et al. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum, 1998, 41: 910-917.
  • 9Choi JH, Suh CH, Lee YM, et al. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol, 2003, 30: 2422-2427.
  • 10Lehmann LE, Weber SU, Fuchs D, et al. Intracellular detection of macrophage migration inhibitory factor in peripheral blood leukocytes. Free Radic Biol Med, 2005, 38:1170-1179.

二级参考文献11

  • 1Bernhagen J, Bacher M, Calandra T, et al. An essential role for macrophage migration inhibitory factor in the tuberculin delayed-type hypersensitivity reaction. J Exp Med, 1996, 183 : 227-282.
  • 2Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocroticoidinduced modulator of cytokine production. Nature , 1995, 377:68-71.
  • 3Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35: 630-640.
  • 4Baugh JA, Bucala R. Macrophage migration inhibitory factor. Crit Care Med, 2002, 30 (1 Suppl) :S27-S35.
  • 5Waeber G, Calandra T, Bonny C, et al. A role for the endocrine and pro-inflammatory madiator MIF in the control of insulin secretion during stress. Diabetes Metab Res Rev, 1999, 15:47-54.
  • 6Mikulowska A, Metz CN, Bucala R, et al. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type Ⅱ-induced arthritis in mice. J Immunol, 1998, 158:5514-5517.
  • 7Shimizu T, Abe R, Ohkawara A, et al. Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis. J Allergy Clin Immunol,1999, 104 (3 Pt 1) :659-664.
  • 8Onodera S, Kaneda K, Mizue Y, et al . Macrophage migration inhibitory factor up-regulation expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem, 2000,275: 444-450.
  • 9陈伟英,尹培达,余学清,陈永雄,梁英杰,关伟明,蓝辉耀.巨噬细胞移动抑制因子在狼疮性肾炎中的作用[J].中华肾脏病杂志,1998,14(1):15-18. 被引量:14
  • 10陈伟英,阳晓,尹培达,陈永雄,关伟明,余学清.慢性移植物抗宿主病狼疮样肾炎小鼠巨噬细胞移动抑制因子的表达及作用[J].中华风湿病学杂志,2002,6(1):18-20. 被引量:5

共引文献9

同被引文献64

  • 1方芳,陈伟英.巨噬细胞移动抑制因子在机体炎症反应中的作用及其机制[J].国外医学(内科学分册),2004,31(5):210-213. 被引量:12
  • 2连帆,杨岫岩,梁柳琴,叶玉津,詹钟平,许韩师.血清铁蛋白水平对成人斯蒂尔病诊断的临床价值[J].中华风湿病学杂志,2005,9(6):338-341. 被引量:52
  • 3Efthimiou P, Kontzias A, Ward CM, et al. Aduh-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol, 2007, 3: 328-335.
  • 4Kutukculer N, Caglayans S. Plasma and synovial fluid soluble CD23 concentrations in children with juvenile chronic arthritis. Autoimmunity, 1998, 27: 155-158.
  • 5Zak M, Pedersen FK. Juvenile chronic arthritis into adulthood: a long-term follow-up study. Rheumatology (Oxford), 2000, 39: 198 -204.
  • 6Chen DY, Lan JL, Lin FJ, et al. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease. Ann Rheum Dis, 2004, 63: 1300-1306.
  • 7Fujii T, Nojima T, Yasuoka H, et al. Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease: association with chronic articular disease. Rheumatology (Oxford), 2001, 40: 1398-1404.
  • 8Saikl O, Uda H, Nishimoto N, et al. Adult Still's disease reflects a Th2 rather than a Thl cytokine profile. Clin Immunol, 2004, 12: 120-125.
  • 9Nakanishi K, Yoshimoto T, Tsutsui H, et al. Interleukin-18 is a unique cytokine that stimulates both Thl and Th2 responses depending on its cytokine milieu. Cytokine Growth Factor Rev, 2001, 12: 53-72.
  • 10Yoshimoto T, Min B, Sugimoto T, et al. Nonredundant roles for CD1d-restricted natural killer T ceils and conventional CD4^+ T ceils in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice. J Exp Med, 2003, 197: 997-1005.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部